# Angstrom Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/angstrom-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Solana Beach, US
- Website: www.angstrominc.com
- Latest round: Series D (Jan 1, 2009)
- Investors on record: 1

## About

Angstrom Pharmaceuticals, Inc. is dedicated to providing innovative pricing solutions that enhance operational efficiency for businesses through timely pricing responses and a streamlined request process.Founded in 1996, Angstrom Pharmaceuticals, Inc. is located in Solana Beach, US. The company focuses on delivering pricing request services to businesses and has engaged in 7 deals as of January 2009. The recent funding round raised USD 2.00 mn from Pacific Gate Company Ltd., totaling USD 2.00 mn since inception. The firm was established by Himmat Singh, Janice H, and Yasser Ghassemi, with Arif Khan serving as the CEO.Angstrom Pharmaceuticals, Inc. specializes in providing solutions that streamline pricing processes for its clients. The core offering includes a pricing request service that guarantees a response within 24 business hours, targeting small to medium-sized enterprises across various sectors in North America, primarily the United States and Canada.Angstrom Pharmaceuticals, Inc. generates revenue through its pricing request service, operating on a transactional basis. Clients submit inquiries and receive pricing within a specified timeframe, which supports B2B interactions. The service structure involves one-off transactions, allowing clients to request pricing without long-term commitments, which aids them in negotiating purchases and managing budgets effectively.Looking ahead, Angstrom Pharmaceuticals, Inc. plans to develop new pricing solutions aimed at enhancing client offerings, though specific release dates are not disclosed. The company intends to expand its presence into additional geographic markets in North America by leveraging the recent funding secured in January 2009, which will support its growth initiatives and further strengthen its service capabilities.

## Funding rounds

- Series D, Jan 1, 2009 — Enhanced Capital

## Investors

- Enhanced Capital (https://capitalatlas.ai/funds/enhanced-capital) — Series D